SCHEMBL5269148

SCHEMBL5269148

NC(=O)[C@@H](N)Cc1ccc(OP(=O)(O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ANPEP P15144 1/20 0.45
▸ LAP3 P28838 1/20 0.45
▸ GRB2 P62993 3/20 0.44
▸ PTPRC P08575 1/20 0.43
▸ SRC P12931 2/20 0.43
▸ BLM P54132 1/20 0.42
▸ PTPN1 P18031 2/20 0.42
▸ ITGB3 P05106 1/20 0.41
▸ ITGA2B P08514 1/20 0.41
▸ SLC7A5 Q01650 2/20 0.41
▸ PLAU P00749 1/20 0.41
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ XIAP P98170 1/20 0.40
▸ CYP2C19 P33261 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TPH1 P17752 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14365819 1.00 ANPEP (0.45) ANPEPLAP3GRB2PTPRCSRC
Dexfosfoserine SCHEMBL5578988 0.88 PTPRC (0.44) ANPEPLAP3PTPRCPTPN1ITGB3
SCHEMBL1152 0.87 PTPRC (0.57) ANPEPLAP3GRB2PTPRCSRC
SCHEMBL4066744 0.87 PTPRC (0.57) ANPEPLAP3GRB2PTPRCSRC
SCHEMBL3626587 0.87 PTPRC (0.57) ANPEPLAP3GRB2PTPRCSRC
SCHEMBL273663 0.87 PTPRC (0.57) ANPEPLAP3GRB2PTPRCSRC
SCHEMBL29613927 0.86 PTPRC (0.56) ANPEPLAP3GRB2PTPRCSRC
SCHEMBL19615883 0.86 PTPRC (0.56) ANPEPLAP3GRB2PTPRCSRC
SCHEMBL29567635 0.86 PTPRC (0.56) ANPEPLAP3GRB2PTPRCSRC
Phosphoric Acid SCHEMBL3476886 0.86 PTPRC (0.56) ANPEPLAP3GRB2PTPRCSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070269902-A1 Antibody complexes and methods for immunolabeling MOLECULAR PROBES, INC. 2007-11-22 — — US claimed
US-20060160068-A1 Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker MOLECULAR PROBES, INC. 2006-07-20 — — US claimed
WO-2005050206-A2 COMPETITIVE IMMUNOASSAY MOLECULAR PROBES, INC. (US) 2005-06-02 — — WO claimed
US-20070269902-A1 Antibody complexes and methods for immunolabeling MOLECULAR PROBES, INC. 2007-11-22 — — US disclosed
US-7282339-B2 Competitive immunoassay INVITROGEN CORPORATION (US) 2007-10-16 — — US disclosed
US-20060160068-A1 Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker MOLECULAR PROBES, INC. 2006-07-20 — — US disclosed
WO-2005050206-A2 COMPETITIVE IMMUNOASSAY MOLECULAR PROBES, INC. (US) 2005-06-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160068-A1 Fluorescent phosphophenol ligand analog of a reporter moleculeof a borapolyazaindacene, a coumarin, a xanthene, a cyanine, a fluorescent protein, or a phosphorescent dye covalently bonded through a linker BRPF1, YIPF5, CHAMP1 ANPEP 1179/4885LAP3 862/4885GRB2 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback